Abstract
Objective: To establish a method to evaluate the effects of chemosensitizer on P-glycoprotein using 99mTc-MIBI, and observe the changes of 99mTc-MIBI uptake kinetics and P-glycoprotein levels after using verapamil in MDR human breast cells MCF-7/Adr. Methods: MDR breast carcinoma cells, MCF-7/Adr, were incubated and different protocols were performed. Protocol I: a chemosensitizer, verapamil (10 µmol/L), was added into cell culture medium, while in control group, the same volume of DMEM was given. Cells were harvested after 2 h incubation with 99mTc-MIBI. Protocol II: Verapamil (10 µmol/L) was added into cell culture medium and incubated for 20 min, 40 min, 60 min, 80 min, 8 h, 24 h, 48 h and 72 h respectively. Cells were harvested after 2 h incubation with 99mTc-MIBI. The radioactivity of the cells was measured and P-glycoprotein expression levels were determined with immunohistochemical stain. Results: Protocol I: After 2h incubation with verapamil the cellular uptake of 99mTc-MIBI was remarkably higher than control group (t=2.33, P<0.05), but there was no difference in P-glycoprotein expression levels between two groups (P<0.05). Protocol II: In verapamil group, 99mTc-MIBI uptake was increased with incubation time prolonging (F=58.2, P<0.05). When verapamil incubation time surpassed 8 h the 99mTc-MIBI uptake negatively correlated to the P-glycoprotein expression levels (r=-0.73, P<0.01). However, when incubation time was less than 80 min, there was no correlation between 99mTc-MIBI accumulation and P-glycoprotein levels (r=0.16, P>0.05). Conclusion: 99mTc-MIBI may be used to evaluate the qualitative as well as quantitative change of P-glycoprotein expression levels induced by the chemosensitizer, verapamil.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
ZHANG, Z., ZHANG, X., WU, H. et al. Using 99mTc-MIBI to Evaluate the Effects of Chemosensitizer on P-glycoprotein in Multidrug-resistant Carcinoma Cells . Chinese-German J Clin Oncol 4, 83–85 (2005). https://doi.org/10.1007/s10330-004-0222-3
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10330-004-0222-3